Clinical Trials · NCT00454571
Pazopanib Hydrochloride After Leuprolide Acetate or Goserelin Acetate in Treating Patients With Relapsed Prostate Cancer
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- National Cancer Institute (NCI)
- Enrollment
- 37
- Start date
- Jun 2006
- Locations
- 2 sites, United States
- Primary endpoint
- Median Time to PSA Progression